Skip to search formSkip to main contentSkip to account menu

SLV 313

Known as: SLV-313, SLV313 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
2007
2007
Combining antagonist/partial agonist activity at dopamine D2 and agonist activity at serotonin 5-HT1A receptors is one of the… 
Highly Cited
2006
Highly Cited
2006
A new generation of proven or potential antipsychotics, including aripiprazole, bifeprunox, SSR181507 and SLV313, exhibit agonist… 
Highly Cited
2006
Highly Cited
2006
The dopamine D1/D2 agonist apomorphine (0.63 mg/kg) disrupted prepulse inhibition (PPI) of acoustic startle in rats, a model of… 
Highly Cited
2005
Highly Cited
2005
Several novel antipsychotics, such as aripiprazole, bifeprunox, SSR181507 [(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4… 
Highly Cited
2005
Highly Cited
2005
Serotonin 5-HT1A receptors are promising targets in the management of schizophrenia but little information exists about affinity…